Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

NCT02997956 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped funding issues

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Tocilizumab
PROCEDURE: Transcatheter Arterial Chemoembolization

Sponsor

University of Michigan Rogel Cancer Center